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Abstract
Introduction: Smooth muscle cell contraction is an essential function of arteries and relies on the integrity of the
actin-myosin apparatus. The tissue-specific α2-smooth muscle actin, encoded by ACTA2, is predominantly expressed
in vascular smooth muscle cells. ACTA2 mutations predispose to development of aortic aneurysms and early onset
coronary and cerebrovascular disease. Based on arteriographic findings, a distinct cerebrovascular disease has been
proposed for ACTA2 heterozygous patients carrying the R179H mutation.
Results: We present the first integrated analysis of a severely compromised patient with the R179H mutation and define
the arterial pathology of ACTA2-related cerebrovascular disease. Histologically, striking morphological abnormalities were
present in cerebral arteries of all sizes. Massive intimal smooth muscle cell proliferation, fragmentation of the elastic
laminae and medial fibromuscular proliferation characterized large arteries whereas prominent vessel wall thickening,
fibrosis and smooth muscle cell proliferation were unique changes in small arteries. The medial fibrosis and smooth
muscle cell proliferation explain the characteristic radiologic appearance of “straight arteries” and suggest impaired
function of mutant smooth muscle cells. Actin three-dimensional molecular modeling revealed critical positioning of R179
at the interface between the two strands of filamentous actin and destabilization of inter-strand bundling by the R179H
mutation, explaining the severe associated phenotype.
Conclusions: In conclusion, these characteristic clinical and pathologic findings confirm ACTA2-related cerebrovascular
disease as a new cerebrovascular disorder for which new therapeutic strategies need to be designed.
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Introduction
Smooth muscle cells (SMCs) form the muscle layers of
tubular viscera and blood vessels [1]. Their contractile
activity, generated by the actin-myosin complex, pro-
vides blood vessels and tubular viscera with motility,
tonus and compliance. Unlike skeletal muscle fibers, in
which the actin-myosin apparatus is organized into sar-
comeres, the contractile filaments in SMC crisscross ob-
liquely through the cell forming a lattice-like network
[2]. In addition to serving a contractile function, SMCs
synthesize extracellular matrix (ECM) components such
as collagen, elastin and proteoglycans, similar to fibro-
blasts [3].
Actin is the most abundant protein in many cell types. It
exists as a 42-kDa globular (G)-actin monomer and, upon
poymerization, as a double-stranded helical filamentous
(F)-actin structure. Six isoforms of actin encoded by differ-
ent genes are present in humans, of which two α isoforms
are selectively expressed in skeletal and cardiac muscles,
and two cytoplasmic isoforms, β and γ, are ubiquitously
expressed in muscle and non-muscle cells [4]. Two iso-
forms of smooth muscle actin (SMA), α2-SMA and
γ-SMA, are present in SMCs in various proportions de-
pending on the organ. Whereas γ-SMA is preferentially
expressed in viscera, α2-SMA is highly expressed in vascu-
lar SMCs. Interestingly, veins but not arteries, express high
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levels of γ-SMA in addition to α2-SMA [5]. α2-SMA is
encoded by ACTA2 on chromosome 10q23.31.
Heterozygous ACTA2 mutations predispose to thoracic
aortic aneurysm disease (TAAD) [6]. Mutations can occur
de novo and the disease has an autosomal dominant mode
of transmission. A subset of ACTA2 mutations also cause
early onset coronary artery disease (CAD) and stroke [7].
The stroke phenotype has been previously described as a
form of moyamoya disease (MMD) [7], but recent studies
showing lack of susceptibility for MMD on chromosome
10q23 [8, 9] and a different radiologic appearance of the
cerebral blood vessels suggest that a distinct cerebrovascular
disease is associated with ACTA2 mutations [10]. Among
the ACTA2 mutations, the one resulting in the R179H
change in α2-SMA confers a particularly severe cerebral
arteriopathy that differs from classical MMD [10, 11]. Other
ACTA2 mutations predisposing to stroke have been re-
ported, such as those resulting in R258C/H and R39H
changes [7].
In this study, we performed an integrated clinical, radio-
logic and pathologic analysis of a unique case harboring the
R179H mutation, extending and completing previously re-
ported analyses [10, 11]. Structural modeling of R179H and
other ACTA2 mutations involved in the stroke syndrome
showed a common positioning on the actin inter-strand
surface responsible for F-actin double strand bundling, pro-
viding a molecular basis for the new ACTA2-related cere-
brovascular disease (ARCD) entity.
Material and methods
Autopsy, histology and digital analysis
These studies were performed in compliance with the eth-
ical guidelines of the Helsinki Declaration and approved
by the University of Texas Southwestern Medical Center
and Parkland Hospital Health Center ethical committees
for research on human subjects. The genetic identifica-
tion, brief clinical history and radiologic appearance of the
patient carrying the heterozygous ACTA2 mutation result-
ing in the R179H change was described in the addendum
[12] and as patient 6 [10], 4 years before she expired. Her
autopsy and that of a gender, race and age-matched con-
trol patient succumbing of cirrhosis were performed in ac-
cordance to the UT Southwestern/Parkland Hospital
regulations. These patients were of normal weight and
comparable height and were free of other risk factors for
cardiovascular disease, such as smoking, diabetes, hyper-
cholesterolemia, hypertension or obesity. Representative
sections were obtained from all the organs, including
aorta. Brains were fixed for 2 weeks in formalin and the
following cerebral arteries were carefully dissected prior to
sectioning: supraclinoid internal carotid arteries (ICAs),
middle cerebral arteries (MCAs), anterior cerebral arteries
(ACAs), posterior communicating arteries (PComs), pos-
terior cerebral arteries (PCAs), basilar artery, vertebral
arteries (VAs), superior cerebellar arteries and posterior
inferior cerebellar arteries. Three 2-mm long fragments
were obtained when possible for each artery. Paraffin-
embedded sections were processed for hematoxylin-eosin
(H&E), Masson trichrome and Verhoeff van Gieson elastic
stains for all the arteries. Immunohistochemistry (IHC) was
performed on selected sections with α-SMA antibody
(clone 1A4, pre-diluted, Ventana Medical Systems, Tucson,
AZ). Images were acquired at various magnifications with
an Aperio Scanscope CS2 whole slide image system (Leica
Biosystems, San Diego, CA) and the measurements of
thickness or diameter were performed by using ImageScope
software, version 12.1.0.5029 on images at 20x magnifica-
tion. Measurements of large artery intima and media thick-
ness were performed on the H&E sections of the arterial
fragment showing the thickest intima, at maximum and
mean thickness, respectively. Measurements of the small
vessel wall were performed at mean thickness and caution
was taken when vessels were not circular. The measure-
ments of small vessel lumen diameter were performed on
α-SMA labeled sections and, when the lumen was elliptic
rather than circular, the formula (D + d)/2 was used, where
D is the long axis and d, the small axis of the ellipse. SMC
nuclei were counted in random fields of large artery media,
in a range of 130–361 nuclei/field, and normalized to area,
by using the analysis tools in Adobe Photoshop CS6,
version 13.0 (Adobe Systems Inc., San Jose, CA).
Radiologic imaging and analysis
Cross sectional imaging studies, including computed tom-
ography (CT) and magnetic resonance imaging (MRI)
performed as part of routine clinical care and available from
the hospital picture archiving and communication system
(PACS), were reviewed by a neuroradiologist. Imaging find-
ings were compared to published literature regarding
ACTA2mutations and MMD. Measurements of luminal di-
ameters and cross sectional areas of the main intracranial
arteries were performed on source images of a CT angiog-
raphy study of the patient, as well as of an age and gender
matched second normal control different from the autopsy
control, by using the Osirix open source DICOM viewer
[13]. Multiplanar reformats of isotropic CT data were per-
formed to obtain long and short axis views of the arteries of
interest. Linear measurements were obtained for luminal
diameter in the mid portion of the vessels on long axis
views and region of interest circular measurements were
obtained for area measurements in the short axis views.
Statistical analysis
Numerical data were examined for normality of distribu-
tion and expressed as mean ± SEM by using the Graph-
Pad Prism program (GraphPad Software, La Jolla, CA).
The two-way ANOVA test in GraphPad Prism was used
for comparison across the control and mutant large
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vessels series in Figs. 1c, b and 2c and the two-tailed t-
test with Welch’s correction for variances significantly
different was used to analyze the differences between
groups for the rest of the analyses. Statistical significance
was considered for P< 0.05. Graphs were plotted with
GraphPad Prism program.
3D modeling
The various α2-actin mutations were mapped and
aligned in the monomeric α1-actin 3D structure (Protein
Data Base accession number 1J6Z). The models of wild-
type or mutant α2-actin residues were generated by
using PyMol (Version 1.5.0.4 Schrodinger, LLC), as pre-
viously described [14].
Results
The characteristic clinical and angiographic features of
ARCD
A 31-year-old female was brought unresponsive to the
emergency room by her husband. Upon arrival at an
outside hospital, the patient was nonverbal, not follow-
ing commands and without purposeful movements.
There was suspicion of seizure activity due to face and
finger twitching, and the patient was intubated for air-
way protection. The patient had a complex prior medical
history including multiple previously repaired aneurysms
(aortic root, arch and right axillary artery at age 25 years,
and thoracoabdominal aorta at age 26 years), surgical
closure for a persistent ductus arteriosus in childhood,
congenital mydriasis, intestinal malrotation diagnosed at
laparotomy at age 2 years, left salpingo-oophorectomy,
colecystectomy at age 23, and obstructive and restrictive
chronic lung disease. The patient also had a history of
left superficial temporal artery encephalodural synangio-
sis 2 years and 9 months prior, due to diagnosed MMD,
associated with body paresthesias and transient weak-
ness. The constellation of vascular abnormalitites that
include aortic aneurysms and persistence of patent
ductus arteriosus, with involvement of SMCs in other
organs leading to congenital absence of the iris, malrota-
tion of the gut and primary pulmonary hypertention was
previously described in individuals with ACTA2 muta-
tions resulting in a change at R179 and was classified as
multisystemic smooth muscle dysfunction syndrome
[12]. The brief clinical and radiologic description of this
patient carrying the R179H mutation was included in
the addendum of the latter study [12] and was also men-
tioned in the table (patient 6) of the study by Munot et
al. [10]. However, her brain imaging findings are com-
prehensively described below, in this study. A brain MRI
at the time of admission revealed large left MCA and bi-
lateral ACA infarcts (Fig. 1a, red arrows), with additional
evidence of chronic small vessel white matter disease
(periventricular hyperintensities; Fig. 1a, yellow arrow)
and postsurgical findings related to prior left pterional
craniotomy for revascularization. Head CT confirmed a
large hypodense area of acute infarction involving the
left MCA and bilateral ACA territories. The patient was
admitted to the Neurology intensive care unit for sup-
portive care. At arrival, the patient was comatose with
Glasgow Coma Score of 7/15. An electroencephalogram
revealed no evidence of seizure activity. Suppression of
background activities within the left frontocentral region
was observed, corresponding to the patient’s ischemic
stroke. Follow-up head CTs at one and two days after ar-
rival did not demonstrate evidence of hemorrhagic
transformation, but showed progression of ischemic in-
jury in the posterior left MCA territory, worsening
edema, mass effect and rightward midline shift. The
family deferred surgical decompression according to the
patient’s previously stated requests. The patient expired
later on the same day and a postmortem examination
was requested.
Review of patient’s prior neuroimaging studies demon-
strated findings consistent with her history of ACTA2
mutation-related vasculopathy. Importantly, the CT
angiography demonstrated an unusual straight course of
most of the intracranial arteries and an absence of the
characteristic collaterals seen in MMD (Fig. 1b). To
examine the capacity of the large cerebral vessels, we
performed measurements on CT angiography images
of the luminal cross sectional area and diameter
(Additional file 1: Figure S1). Both parameters were
significantly lower in the ACTA2-mutant patient com-
pared to a normal age- and gender-matched control
(Fig. 1c), suggesting chronic hypoperfusion of the
brain. Exceptions were noted in the sites of increased
compensatory flow, such as for the left ICA that sup-
plied the right ACA territory through the azygos
ACA in addition to the normal left ACA territory,
and for the posterior communicating arteries, that
supplied the main flow to PCAs due to hypoplasia of
the P1 segments of the PCAs (Fig. 1d).
Marked abnormalities of intima and media in ACTA2
mutant large-size cerebral arteries
Gross examination of the brain showed mildly increased
weight (1300 g) with signs of edema of the left cerebral
hemisphere: widening and flattening of the gyri, soften-
ing of the parenchyma, left lateral ventricle narrowing
with mild midline shift, mild left subfalcine herniation
and left uncal herniation (Additional file 1: Figure S2).
Colpocephaly-like dilatation of the trigone and oc-
cipital horns of the lateral ventricles, was also noted
(Additional file 1: Figure S2, red arrow). The microscopic
examination of representative sections confirmed the
radiological findings of infarct and showed generalized
acute neuronal and glial necrosis, mild neutrophilic





































Fig. 1 Radiologic characteristics of ARCD. a. MRI axial diffusion weighted image (DWI) and corresponding apparent diffusion coefficient (ADC)
map, and coronal T2W-FLAIR image showing acute infarct with restricted diffusion involving the territories of the left MCA and bilateral ACAs (red
arrows). Chronic periventricular leukoencephalopathy (yellow arrows) appears with hyperintensity on FLAIR images and increased diffusivity on
ADC map. b. CT angiography demonstrating the straight course of most of the intracranial arteries, as well as lack of basal collaterals, which are
typically seen in MMD. Narrowing of the supraclinoid segment of right ICA (yellow arrow) and bilateral MCAs (red arrows), and the azygos
configuration of the A2 segment of ACA (blue arrow) are also shown. The missing right ACA A1 segment is indicated by a punctuated line and
explains involvement of bilateral ACA territories with a left ICA occlusion. c. In vivo lumen diameter and area measurements by CT angiography
(see also Additional file 1: Figure S1). The arterial measurements are compared to a normal age and gender-matched control. No left posterior
communicans artery (PCom) was identified for the control. Control and mutant datasets are compared by two-way ANOVA. d. The configuration
of the circle of Willis in the ARCD patient shows a combination of anatomic variants in both the anterior – lack of A1 of right ACA and common
anterior azygos trunk- and posterior parts - “fetal-type” variant of PCAs with hypoplastic P1 segments (blue arrowheads). A drawing depicting the
circle of Willis is shown for comparison
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reaction and endothelial swelling in the left MCA, ACA
and right ACA territories (Additional file 1: Figure S3).
Occasional acute ischemic neuronal necrosis was also
seen in the right basal ganglia and bilateral thalami (not
shown), suggesting global ischemia.
Gross examination of the major arteries of the cerebral
circulation confirmed the marked narrowing of the
lumen of the right supraclinoid ICA, the unilateral azy-
gos configuration of ACAs and the hypoplasia of the P1
segments of the PCAs noted radiographically (Add-
itional file 1: Figure S4). Although these variants in the
anterior and posterior parts of the circle of Willis circu-
lation account each for 2–10 % in the general population
[15], the combination of these variants in a single indi-
vidual most likely reflects a developmental abnormality.
A comparative histological analysis was further carried
out between the ACTA2 patient’s arteries and those of a
gender and age-matched control (Fig. 2). H&E staining
revealed marked thickening of the intima in all major ar-
teries of the anterior cerebral circulation and variable in-
timal thickening of the arteries of the posterior cerebral
circulation (Fig. 2a-b). The intimal thickening explains
the decreased lumen diameter and area observed angio-
graphically (Fig. 1c) and the propensity to develop
thrombosis. Indeed, both the left MCA and right ICA














































P = 0.0005 
Media
P = 0.008 
Fig. 2 Analysis of large cerebral arteries. a. H&E of major branches of the circle of Willis and vertebral arteries (VA). Note marked splitting between the
intima and media in the ACTA2 mutant (arrows), resulting in complete separation of the tunics in the right MCA (insert shows media). b-c. The thickness of
intima (b) and of media (c) were measured at maximum and mean layer thickness, respectively. Control and mutant datasets are compared by
two-way ANOVA
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A striking splitting between the intima and the
media at the level of the internal elastic lamina was
observed in the ACTA2 mutant arteries compared to
arteries from the age-matched control patient, espe-
cially in the anterior circulation (Fig. 2a arrows). A
minimal degree of splitting has been described as an
artifact and attributed to the postmortem contraction
of the media [1]. The excessive splitting present in
the ACTA2 mutant arteries is a postmortem artifact
as well but suggests additional deregulation of adhe-
sion between intima and media.
The measurement of the average thickness of the
media revealed comparable medial thinning in both an-
terior and posterior cerebral circulations of the ACTA2
mutant (Fig. 2c). Exceptions were noted in the cases of
compensatory flow, such as for the left ICA and the two
posterior communicating arteries.
Special stains for elastic fibers (Verhoeff van Gieson)
and ECM (Trichrome), and IHC with α-SMA antibody
for SMCs revealed severe changes present in ACTA2
mutant large cerebral arteries (Fig. 3). Overall, the com-
bined wall thickness of the ACTA2 mutant arteries was
significantly increased compared to normal arteries due
to increased intima thickness (Fig. 3, H&E, double-
headed arrows). The elastic laminae, labeled in black by
the silver elastic stain, were less folded (Fig. 3, elastic
stain, red arcs) and were thickened, split and fragmented
(Fig. 3, elastic stain, red bracket). A modified collagen
content in areas highlighted by the elastin stain was sug-
gested in the trichrome stain (Fig. 3, trichrome stain, red
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Fig. 3 Large artery changes in ARCD. Serial sections of left MCA labeled with H&E, elastic and trichrome special stains and with α-SMA IHC show
thickened arterial walls (double headed arrows), flattening (red curve), splitting and disorganization (red bracket) of the internal elastic lamina,
marked fibrosis of the media (black arrows) where SMCs stain red and increased collagen stains blue with Trichrome, and SMC proliferation (blue
arrow) of intima in the ACTA2 mutant as compared to control. The numbers of SMC nuclei from the media of the indicated large cerebral arteries
were counted on random fields from H&E sections, normalized to area and expressed as mean ± SD. Control and mutant groups for each artery
were compared by t-test
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bracket). An increased amount of ground substance in
the thickened intima was also apparent. One of the most
striking abnormalities encountered in all ACTA2 mutant
arteries was the substantial increase in collagen within
the media (Fig. 3, trichrome stain, arrows). This exces-
sive collagen production was accompanied by a mild in-
crease in the number of SMCs in the media of large
arteries (Fig. 3, graph). Together with the overall in-
creased wall thickness, the severe media fibrosis most
likely explains the characteristic, and possibly pathogno-
monic, straight appearance of the cerebral arteries on
imaging studies (Fig. 1b).
IHC for α-SMA showed massive SMC proliferation in
the intima and SMC dissection through the split internal
elastic lamina (Fig. 3, α-SMA, blue arrow and red
bracket, respectively).
Unique ACTA2 mutant phenotype of small-size arteries
Examination of the small size arteries in various regions
of the brain revealed significant abnormalities in the
ACTA2 mutant vessels (Fig. 4). Analysis of the wall
thickness of leptomeningeal small size arteries in two re-
gions of the brain, occipital and hippocampal, showed
significantly thicker ACTA2 mutant arteries compared to
control (Fig. 4a, graph).
Likewise, the walls of the patient’s small intraparenchy-
mal arteries were significantly thicker than those from
the control case arteries, whereas veins showed no dif-
ference (Fig. 4b, upper graph). The sparing of the veins
may reflect the presence of γ-SMA in these vessels [5].
The measurement of the lumen diameter showed a
trend towards a smaller lumen in the ACTA2 mutant, al-
though the majority of the small arteries appeared to
have lumens comparable to those in the control case.
Luminal dimensions of small veins were similar in pa-
tient and control sections (Fig. 4b, lower graph). Histo-
logical analysis of the arterial walls revealed massive
SMC proliferation and marked fibrosis (Fig. 4b, lower
panels), similar to that noted in the media of large-size
arteries. The marked proliferation of SMCs in the small
size arteries appears to be a unique feature of this dis-
ease and has not been observed in other cerebral small
size vessel diseases [16].
Overall, the small arteries had thickened walls in all
brain territories (Fig. 4c), with the highest thickness of
2.5-4 fold more than control in the basal ganglia, cere-
bellum, choroid plexus and hippocampal leptomeninges.
Noteworthy, these abnormalities were also present in
the subcortical white matter (Additional file 1: Figure
S5). Although small infarcts or hemorrhages were not
observed, radiologic signs of periventricular leukoaraio-
sis (Fig.1a, yellow arrow), corresponding microscopically
to areas of rarefaction of the periventricular neuropil
and axonal damage (Additional file 1: Figure S6),
support the possibility of chronic ischemic injury. Add-
itional evidence of chronic ischemic damage in the form
of substantial neuronal loss was noted in the hippocam-
pus, particularly in the CA1 region (Fig. 5). This general-
ized chronic arteriopathy might be responsible for
cognitive changes, such as those observed in other her-
editary cerebral small vessel diseases [16], and this as-
pects warrants further in depth clinical investigation.
Systemic manifestations in ARCD: broad involvement of
arterial SMCs
To assess and compare the extent of the vascular disease
in other regions beside the brain, we examined represen-
tative sections of various organs. The aorta showed thin-
ning of the wall formed by the intima and media
(Additional file 1: Figure S7, double headed arrow), in
contrast to cerebral arteries, for which the exuberant in-
timal fibromuscular proliferation accounts for increased
thickness. The prominent loss and fragmentation of the
elastic lamellae (Additional file 1: Figure S7 arrowheads
and elastic stain) replaced by disorganized ECM and
SMCs explains the decreased resistance to blood pres-
sure and the formation of aneurysms. The small arteries
of the aortic vasa vasorum had thickened walls (Add-
itional file 1: Figure S7, arrows), similar to the small ar-
teries in the brain. Similar histopathologic findings of
the aorta have been previously described in patients with
the R179H as well as other ACTA2 mutations, including
that resulting in the R258H change [6, 12].
The large size muscular arteries in various organs,
including those from the kidney, liver and branches
of the aorta, showed intimal fibromuscular prolifera-
tion, although this change was not as extensive as
that seen in the large size cerebral arteries of the an-
terior circulation (Additional file 1: Figure S8A, D).
The small size arteries in the connective tissue and
parenchyma of various organs had thicker walls, simi-
larly to those observed in the brain, indicating that
this is a generalized defect induced by the ACTA2
mutation (Additional file 1: Figure S8A-D). The med-
ial thickening of the myocardial arteries (Additional
file 1: Figure S8C) is similar to the one previously de-
scribed for the subset of ACTA2 mutations predispos-
ing to CAD [7]. Although not as dramatic as the
ischemic changes noted in the brain, evidence of is-
chemic organ damage was seen in the heart, mani-
fested by areas of fibrosis and cardiomyocyte
hypertrophy (Additional file 1: Figure S8C), and in
the kidney, with areas of transcortical glomerulo-
sclerosis along the interlobular artery territory. Inter-
estingly, as previously reported [12], architectural
abnormalities that could not be clearly related to a
vascular dysfunction – specifically panacinar emphy-
sema – were present.
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R179H maps to the interstrand F-actin surface and dis-
rupts F-actin bundling
To dissect the role of ACTA2 mutations in ARCD, we
mapped the position of two of the most pathogenic mu-
tations, R179H and R258H, in a 3D structure model of
actin (Fig. 6a). Whereas R179 localizes to a short β-
strand in actin subdomain 3, R258 is situated in an α-
helix in subdomain 4. Both residues have side chains
pointing to the same surface of the molecule, relatively
at distance from the ADP/ATP binding site (Fig. 6a, b).
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Arteries Veins 
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(n=18) (n=25) (n=20) (n=19) 
(n=17) (n=24) (n=10) (n=10) 
Thickness of ACTA2 small size arteries C
Fig. 4 Small-size artery disease in ARCD. a. H&E of leptomeningeal vessels overlaying the calcarine cortex. The graph shows the distribution and mean ±
SEM of the transmural thickness for leptomeningeal small arteries from two brain regions. b. Analysis of parenchymal small vessels from the cerebellum
shows thickened walls with characteristic SMC proliferation and fibrosis. The quntifications of transmural wall thickness and lumen diameter are shown for
both small arteries and veins. The scoring of lumen diameters was performed on 20 α-SMA labeled vessels in each category. Control and mutant groups
for each category were compared by t-test. c. Distribution of the ACTA2 mutant small size arteries with variable wall thickness across brain regions. +++, ++
and + represent 2.5–4, 1.5–2.5 and <1.5 fold increase vs. control
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The common surface is the one involved in pairing of F-
actin strands [17, 18]. F-actin is a double-stranded fila-
ment resulting from the non-covalent polymerization of
monomeric G-actin via intra-strand and inter-strand
hydrophilic and electrostatic bonds (Fig. 6c). Both resi-
due R179 and R258 have been reported to contribute to
the inter-strand bridging [17]. In the case of R179, a
contact (Fig. 6d) takes place between R179 in subdomain
3 and L112 in subdomain 1 (in gold, Fig. 6d) from one
molecule and K193 and T196 in subdomain 4 (in green,
Fig. 6d) of the paired molecule [17]. The modeling of
the R179H change shows merging of the H179 and L112
side chain projections with significant alteration of the
contact surface (Fig. 6d right panel) that very likely im-
pinges on the inter-strand pairing.
Both R179 and R258 pathogenic mutations have been
described in α2-SMA and γ2-SMA, predisposing for
TAAD/stroke and megacystis-microcolon-intestinal hypo-
peristalsis syndrome, respectively [19]. Remarkably, the
residue R179 (R177 in α1-actin) is the site of ADP-
ribosylation by Clostridium botulinum, perfringens and
difficile C2, iota and transferase CDT toxins, respectively
[20]. ADP-ribosylation at this site results in steric hin-
drance of actin monomer interactions and blockage of
polymerization. Mutagenesis of R179 to D in β-actin has
been shown to significantly lower polymerization rate and
polymer viscosity [21], suggesting a critical role in actin
polymerization. While we modeled the structural effect of
the R179H mutation for the first time in this report, the
role of the R258H mutation that alters the same inter-
strand interface as R179H (Fig. 6a-b) has been extensively
studied [22] and R258H mutagenesis has been shown to
cause F-actin polymerization defects [23, 24].
Discussion
Cerebrovascular disease is a major health problem in de-
veloped countries. An understanding of the heteroge-
neous nature of the abnormalities manifesting clinically
as cerebrovascular disease is paramount for developing
disease-specific therapies. This report represents the first
comprehensive histopathologic analysis of severe cere-
brovascular disease resulting from an ACTA2 mutation
(ARCD), expanding our knowledge of the pathological
spectrum of cerebrovascular disease. ARCD is a systemic
disease that affects arteries of all sizes. The striking his-
topathologic changes of intima and media fibromuscular
proliferation of the arteries in the anterior cerebral cir-
culation underlie the characteristic “straight arteries”
angiographic sign. While the fibromuscular proliferation
of the intima noted in this patient is also a feature of
atherosclerosis and MMD [25–27] several aspects distin-
guish the changes seen in this case from either athero-
sclerosis or MMD. Macrophage accumulation and
cholesterol-rich plaques characteristic of atherosclerosis
were not observed. Several differences with MMD were
noted as well, including decreased folding of the internal
elastic lamina in cross sections as opposed to more com-













Fig. 5 Neuronal depletion in ARCD. H&E sections of the right hippocampus show severe neuronal depletion in ARCD as compared to control,
more prominent in the CA1 region. The right panels represent higher magnification fields (10x) of the CA1 region marked by brackets. Insets
show small parenchymal arteries that have thickened walls in ARCD
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seen in MMD [26]. Additionally, the medial changes evi-
dent in this case - fibrosis and SMC proliferation - differ
from the attenuation of the media in MMD [25, 26].
Perhaps most significantly, the compensatory small vas-
cular collaterals characteristic of MMD were not a fea-
ture of this case, and it is possible that the altered
composition of the arterial walls in ACRD may play a
role in this. In MMD, the collateral vessels and most
likely the revascularization following encephalodural
synangiosis develop as a response to ischemia and re-
lease of angiogenic growth factors, such as vascular
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polymerization
Fig. 6 R179H 3D model and mechanism of action in ARCD. a. Ribbon 3D representation of monomeric α1-actin oriented to view the interstrand
surface shows the 4 actin subdomains (SD), the ADP/ATP-binding site, and the positioning of R179 and R258 on the interstrand surface. b. Surface
projection of ARCD mutations to the same surface as R179 suggests similar mechanisms of actin polymerization disruption. c. Diagram of monomeric
G-actin polymerization into double-stranded F-actin. d. Surface representation shows projection of the R179 side chain to the interstrand surface (left
panel). Also represented are residues involved in interstrand contact: R179 and L112 (in gold) from one actin subunit contact K193 and T196 (in green)
from the paired subunit, as schematized in the cartoon. The contact interface is altered by mutation to H179 (right panel). e. Pathogenesis model of
ARCD. F-actin polymerization from a pool of wild-type (blue) and mutant (red) monomers results in variably defective filaments depending on the
mutant:wild-type monomer ratio and the relative mutant monomer positioning into the F-actin chain. Blue arrows indicate compensatory mechanisms
and red dotted arrows possible intrinsic phenotypes of SMCs with mutant ACTA2
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same compensatory response to ischemia is probably
elicited in ARCD, the growth factors produced in the is-
chemic tissue may not diffuse properly to the endothelial
cells through the thick vasculature. Alternatively, a
structural deficiency of the vessels in ARCD could inter-
fere with the sprouting of the collateral vascular chan-
nels seen in MMD. In this respect, remodeling of the
ECM and maintenance of a balance between angiogenic
and anti-angiogenic factors, which are in part secreted
by SMCs, is necessary for efficient angiogenensis [28].
As the ECM is clearly deregulated in ARCD arteries,
most likely as a direct consequence of impaired secre-
tion by mutant SMCs, future work to delineate these
possibilities might have therapeutic implications for po-
tential revascularization.
ARCD diffusely involved small arteries and showed
histopathologic changes of fibrosis, and SMC prolifera-
tion, leading to increased wall thickness that reached in
some areas 4-fold higher values than the control. These
small vessel changes are unique among hereditary small
vessel arteriopathies that, in contrast to ARCD, are char-
acterized by degeneration of SMCs [16, 29]. This charac-
teristic SMC proliferation was present systemically in
the small vessels of various organs - lymph node me-
dulla, liver, lung, heart, submucosa and serosa of esopha-
gus, stomach and uterus - and in fibroadipose tissue but
not in the sampled abdominal skin. As previously re-
ported, the vasa vasorum in the adventitia had also in-
creased wall thickness [6]. As these patients frequently
undergo multiple surgeries, this disease may be sus-
pected when small vessels with SMC proliferation are
detected.
The generalized arteriopathy of ARCD induced sec-
ondary organ changes, the most prominent and life
threatening being in the brain. These were manifested
by both acute ischemic change, such as stroke, and
chronic ischemic change in the form of leukoencephalo-
pathy and neuronal loss. The MRI T2-weighted hyper-
intensities in the periventricular white matter
(leukoaraiosis) have been previously observed in ACTA2
patients with R179 mutations [10, 12, 30–32] but the
histopathologic basis has not been clearly defined. We
found areas of rarefaction containing axonal swellings
at these sites, similar to lesions described in hereditary
diffuse leukoencephalopathy with axonal spheroids and
sometimes also seen in CADASIL [16, 33]. Moreover,
the colpocephaly, a developmental abnormality that has
been linked to white matter underdevelopment of vari-
ous causes [34], has been also reported later in life in
this patient and in a second patient carrying the R179H
mutation [12]. This colpocephaly-like ventricular dilata-
tion is suggestive of progressive chronic ischemic dam-
age of the periventricular white matter in ARCD
patients. Interestingly, the severe neuronal loss in the
hippocampus, predominantly in the CA1 area, is most
likely attributable to chronic ischemia as well. This find-
ing is similar to the changes described in hippocampal
sclerosis, which are considered to be a consequence of
age-related angiopathy in some cases [35].
ARCD has both common and distinctive features
from other vascular syndromes, the former stemming
most likely from the interplay of secondary compen-
satory mechanisms following arterial injury. To inte-
grate ARCD into the broader field of vascular
disease, we modeled its pathogenesis starting with its
characteristic structural alteration, the R179H α2-
SMA mutation (Fig. 6e). Based on our structure
modeling, the common mechanistic denominator for
the R179H and R258H mutations described in ARCD
[10] is most likely the destabilization of the F-actin
inter-strand interface. Predictably, the severity of
inter-strand bundling disruption depends on the
mutant:wild-type ratio protein concentration and on the
relative position of the mutant protein incorporated into
the actin filament (Fig. 6e). These events may have sec-
ondary allosteric effects on the association of actin with
actin-binding proteins, such as formin, which is required
for nucleation and elongation of F-actin, thus causing se-
vere disruption of F-actin polymerization [22]. Because of
its critical positioning, the mutation of R179 might cause
a more severe disruption of actin polymerization than
other mutations, which may explain the more severe and
generalized phenotype reported for R179 mutations [12].
How the alterations of actin polymerization translate into
the morphogenetic abnormalities observed in the cases of
ARCD is not known. It has been shown that only a small
amount of actin in SMCs undergoes active polymerization
in a submembranous network that serves to strengthen
the membrane for the transmission of force generated by
the contractile apparatus to the extracellular matrix [36].
An abnormal submembranous actin polymerization would
give rise to decreased SMC membrane rigidity and thus
decreased contractility (Fig. 6e). Surprisingly, the ACTA2
knock-out mice share with the human mutant ACTA2 pa-
tients only the blood pressure dysregulation due to con-
tractility impairment. Otherwise, these mice are viable and
do not have morphological cardiovascular defects, most
likely due to compensatory expression of skeletal muscle
actin in their vessels [37]. This suggests a dominant-
negative effect of the mutant α2-SMA on vasculature
morphogenesis with alteration of other SMC functions
than contractility. Indeed, the fibrosis of media and accu-
mulation of abundant ground substance and disorganized
elastin in the intima of the ARCD arteries suggests that
the secretory function of SMCs is deregulated. Whether
SMCs with R179H mutant α2-SMA secrete abnormal
ECM directly or as a consequence of arterial damage due
to inefficient contractility is not clear. Due to similarities
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with other TAADs and cerebral vasculopathies with
abnormal ECM [29, 38], a compensatory secretion of
abnormal ECM is probably taking place (Fig. 6e).
Both elastin knockout mice and humans with supra-
valvular aortic stenosis characterized by loss-of-
function mutations on one elastin allele have uncon-
trolled SMC proliferation in the intima leading to
arterial stenosis and death [3, 39]. It has been shown
that the intimal SMC proliferation results from de-
creased deposition of insoluble elastin and, con-
versely, that addition of insoluble elastin inhibits
SMC proliferation [39]. Strikingly, massive intimal
SMC proliferation was present in most of the large
size cerebral arteries in ARCD, most likely due to
defective elastin deposition [39]. Although this loop
may be involved in the characteristic proliferation of
the SMC population from the media of large arteries
or wall of small arteries, the hypothesis of an intrin-
sic hyperproliferative phenotype of mutant ACTA2
SMCs remains to be explored (Fig. 6e). Notably,
SMCs from ACTA2 knock-out mice proliferate and
migrate more rapidly than control SMCs [40].
Conclusions
In conclusion, this study presents the first comprehen-
sive analysis of cerebrovascular changes in a patient
with ARCD and offers morphological explanations for
many of the clinical findings. The cues that trigger the
global artery morphogenetic defects are yet to be found.
These may not only explain why the correction of the
vascular flow by arterial bypass, a procedure successfully
used in MMD, usually fails in ARCD patients, but also
unravel new treatment options directed to target the ar-
terial obstructive pathology in ARCD.
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